Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	8.48	-30.88	-33.74
Graham Fair Price	-5.51	49.28	52.16
PEG	3569.56	1.84	-0.05
Price/Book	-18.07	1.81	2.21
Price/Cash Flow	43.58	-16.66	-29.53
Prices/Earnings	21.44	-6.44	-8.20
Price/Sales	17.68	19.84	16.86
Price/FCF	43.58	-16.66	-29.53
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	42.72	-0.10	-0.18
Operating Margin	-6.06	-0.80	-0.75
ROA	-6.66	-0.04	-0.04
ROE	-0.07	-0.07	-4.29
ROIC	-0.06	-0.05	13.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	249.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-13.20	0.31	-97.62
EPS QOQ	-1.64	0.04	-97.86
FCF QOQ	-29.25	-0.35	98.81
Revenue QOQ	-0.56	-0.35	37.39
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	348.78	618.82	77.42
Days Sales Outstanding (DSO)	224.50	300.98	34.07
Inventory Turnover	0.26	0.15	-43.64
Debt/Capitalization	0.23	0.22	-3.99
Quick Ratio	1.85	2.07	12.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42.38	39.21	-7.47
Cash	15.11	11.91	-21.17
Capex	-0.71	-0.46	35.20
Free Cash Flow	-3.17	-4.26	-34.37
Revenue	5.55	3.58	-35.58
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.70	4.54	22.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.34	-3.48	-48.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating